Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intraoperative Strict Glycemic Control in Liver Transplantation
NCT00780026Phase 4Completed
- Sponsor
- University of Michigan
- Start
- Jul 2008
- Primary completion
- Sep 2009
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of human insulin in hyperglycemia, sponsored by University of Michigan. Primary endpoints: Infection Rates at 30 days and Number of Participants With One Year Survival Post Transplant at 12 months. Started Jul 2008; status: completed.
02
Drugs
human insulin
03
Conditions
hyperglycemia
Beyond the preview
Go deeper on NCT00780026.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00780026.